The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I/II trial of the multipeptide cancer vaccine IMA910 in patients with advanced colorectal cancer (CRC).
Frank Mayer
No relevant relationships to disclose
Andrea Mayer-Mokler
Employment or Leadership Position - immatics
Stock Ownership - immatics
Elzbieta Nowara
No relevant relationships to disclose
Laszlo Torday
No relevant relationships to disclose
Joerg Ludwig
Employment or Leadership Position - immatics
Stock Ownership - immatics
Sabrina Kuttruff
Employment or Leadership Position - immatics
Stock Ownership - immatics
Toni Weinschenk
Employment or Leadership Position - immatics
Stock Ownership - immatics
Steffen Walter
Employment or Leadership Position - immatics
Stock Ownership - immatics
Harpreet Singh
Employment or Leadership Position - immatics
Stock Ownership - immatics
Carsten Reinhardt
Employment or Leadership Position - immatics
Stock Ownership - immatics